Drawing for MABLAUNCH

USPTO serial 85373673

MABLAUNCH

Reviewed by CopyMark Law Group

Reg. 4189253Status 710
Filing date
Status date
Registration date
Aug 14, 2012
Examiner
RUTLAND, BARBARA A
Law office
PETITIONS OFFICE

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MABLAUNCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Upton Douglass

SUSAN UPTON DOUGLASS FROSS ZELNICK LEHRMAN & ZISSU, P.C.4 TIMES SQUARE, 17TH FLOORNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001(Based on 44(e)) Monoclonal antibodies, cells and cell-lines for scientific, laboratory or medical research and for the use in the manufacture of pharmaceuticals, biochemistry, molecular biologySECTION 8 - CANCELLED—
040(Based on Use in Commerce) Custom manufacture of biochemical, and cell-based assays on behalf of others; custom production of reagents, cells and cell lines on behalf of others; custom manufacture of transgenic products, namely, pharmaceuticals, biopharmaceuticals and proteins; treatment of cells, chemical solutions, DNA delivery vehicles, proteinaceous molecules and nucleic acids for use in the preparation of pharmaceuticals and/or genetic biochemicals and/or molecular biologySECTION 8 - CANCELLEDDec 6, 2010
042(Based on 44(e)) Scientific services, namely, research in the medical and biochemical field, namely, the examination and testing of genes, pharmaceutical and biochemical semi-finished products, test systems for monoclonal antibodies, cells and cell-lines; scientific research concerning culture media for cultivation of monoclonal antibodies, cells and cell-lines, genetically modified material for use in medicines, genetherapy, gene banks and diagnostic purposes, and for the development of medicines, genetherapy, gene banks, diagnostic purposes, biochemistry and molecular biologySECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 15, 2019C8..CANCELLED SEC. 8 (6-YR)—
Aug 14, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 5, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 14, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 29, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 29, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 9, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 7, 2012CHPBPOST PUBLICATION AMENDMENT - ENTERED—
May 3, 2012APETASSIGNED TO PETITION STAFF—
Apr 27, 2012EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Apr 25, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 18, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 13, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 13, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 6, 2012ALIEASSIGNED TO LIE—
Mar 27, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 7, 2012CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 7, 2012COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 27, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2011DOCKASSIGNED TO EXAMINER—
Jul 22, 2011MPMKNOTICE OF PSEUDO MARK MAILED—
Jul 21, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 21, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance